```html

Vertiginous Migraines

What is Vertiginous migraines?

Vertiginous migraine (also called vestibular migraine or migraine‑associated vertigo) is a neurological disorder in which episodes of vertigo (a sensation that you or your surroundings are spinning) occur in conjunction with typical migraine features. It is one of the most common causes of recurrent vertigo, affecting up to 1 % of the general population and up to 10 % of people with migraine headaches (Mayo Clinic; American Academy of Neurology).

Unlike classic migraine attacks, the dominant symptom is dizziness rather than head pain. Nonetheless, many patients still experience a headache, visual aura, photophobia, phonophobia, or nausea during an attack. The condition can be disabling because vertigo interferes with balance, driving, work, and daily activities.

Common Causes

Vertiginous migraine is a primary disorder, meaning it is not caused by another disease. However, several underlying or co‑existing conditions can trigger or worsen attacks. The most frequently implicated factors include:

• Genetic predisposition – A family history of migraine increases risk.
• Hormonal fluctuations – Estrogen changes during menstrual cycles, pregnancy, or menopause can precipitate attacks.
• Stress and emotional tension – Acute or chronic stress is a well‑documented migraine trigger.
• Caffeine or alcohol overuse – Both can provoke migraine‑related vertigo.
• Sleep disturbances – Irregular sleep patterns or sleep apnea may exacerbate symptoms.
• Dietary triggers – Aged cheeses, processed meats, chocolate, and monosodium glutamate (MSG) are common culprits.
• Medications – Certain vasodilators, hormonal contraceptives, or over‑the‑counter pain relievers taken excessively can trigger attacks.
• Environmental factors – Bright lights, strong odors, or noisy settings may set off vertigo.
• Other vestibular disorders – Co‑existing benign paroxysmal positional vertigo (BPPV) or Menière’s disease can make diagnosis challenging.
• Physical exertion – Strenuous exercise or rapid head movements may precipitate an episode.

Associated Symptoms

Vertiginous migraine attacks often last from a few minutes to several days and may be accompanied by a constellation of other migraine‑related signs:

• Headache – Typically unilateral, throbbing, and moderate‑to‑severe.
• Visual aura – Flashes of light, zigzag lines, or temporary loss of vision.
• Photophobia & phonophobia – Heightened sensitivity to light and sound.
• Nausea & vomiting – Common in both migraine and vertigo.
• Unsteady gait or ataxia – Difficulty walking straight during an attack.
• Tinnitus or ear fullness – A ringing or feeling of pressure in the ears.
• Difficulty concentrating (“brain fog”).
• Fatigue – Often lingering after the vertigo resolves.

When to See a Doctor

Most vertiginous migraine episodes are benign, but certain features should prompt an earlier medical evaluation:

• First‑time vertigo lasting longer than 24 hours.
• Sudden, severe vertigo with vomiting, hearing loss, or facial weakness (possible stroke or inner‑ear disease).
• Vertigo that interferes with work, driving, or daily activities.
• New neurological symptoms such as double vision, numbness, or slurred speech.
• History of head trauma, tumor, or infection that could mimic migraine.
• Symptoms that do not improve with standard migraine or vestibular treatments.

Prompt assessment helps rule out life‑threatening causes and initiates appropriate therapy.

Diagnosis

Diagnosing vestibular migraine is primarily clinical, relying on a detailed history and exclusion of other disorders. The International Headache Society (IHS) and Barany Society have set criteria that most clinicians follow:

Step‑by‑step evaluation

1. Medical history
   • Frequency, duration, and pattern of vertigo attacks.
   • Presence of migraine headaches or aura.
   • Known migraine triggers, menstrual cycle influence, medication use.
2. Physical & neurological exam
   • Assess gait, balance, ocular movements, and cranial nerves.
   • Typical vestibular exams (Dix‑Hallpike, head‑impulse test) help rule out BPPV or vestibular neuritis.
3. Audiologic and vestibular testing
   • Electronystagmography (ENG) or video‑oculography (VOG) to record eye movements.
   • Videonystagmography (VNG) or rotary chair testing for balance function.
   • Audiometry to exclude hearing loss that would suggest Menière’s disease.
4. Imaging
   • MRI of the brain (with and without contrast) is ordered when stroke, tumor, or demyelinating disease is a concern.
   • CT is rarely needed unless acute hemorrhage or bone abnormalities are suspected.
5. Laboratory work‑up (selective)
   • Complete blood count, metabolic panel, thyroid function – to exclude metabolic causes.
   • Inflammatory markers if autoimmune vestibular disease is in the differential.

When the patient meets the IHS criteria (≥5 episodes of vestibular symptoms lasting 5 minutes–72 hours, a personal or family history of migraine, and at least one migraine feature during ≥50 % of episodes) and other causes have been excluded, the diagnosis of vertiginous migraine is confirmed.

Treatment Options

Therapy is individualized and often combines acute symptom control with preventive strategies.

Acute (abortive) treatments

• Triptans (e.g., sumatriptan 6 mg subcutaneously) – Effective for migraine‑related vertigo when administered early.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – Ibuprofen 400‑600 mg or naproxen 500 mg can reduce headache and dizziness.
• Antiemetics – Metoclopramide 10 mg IV/PO or prochlorperazine for nausea and vestibular inhibition.
• Vestibular suppressants (short‑term only) – Meclizine 25‑50 mg or benzodiazepines (e.g., clonazepam) for severe vertigo, used sparingly to avoid dependence.
• Hydration & caffeine withdrawal – Dehydration can worsen vertigo; limiting caffeine may improve response.

Preventive (prophylactic) medications

• Beta‑blockers – Propranolol 40‑160 mg daily; useful for both headache and vestibular symptoms.
• Calcium channel blockers – Verapamil 80‑240 mg daily; shown to reduce vertigo frequency.
• Anticonvulsants – Topiramate 25‑100 mg or valproic acid 500‑1000 mg; effective for migraine prevention.
• Tricyclic antidepressants – Amitriptyline 10‑50 mg at bedtime; helpful for patients with comorbid mood disorders.
• CGRP monoclonal antibodies – Erenumab, fremanezumab, or galcanezumab for refractory cases (FDA‑approved for migraine; off‑label for vestibular migraine).

Non‑pharmacologic therapies

• Cognitive‑behavioral therapy (CBT) – Addresses stress, anxiety, and migraine trigger awareness.
• Vestibular rehabilitation therapy (VRT) – Tailored balance exercises improve central compensation and reduce vertigo episodes (Cleveland Clinic).
• Lifestyle modifications
  • Maintain a regular sleep schedule (7‑9 hours).
  • Stay hydrated; limit alcohol and caffeine.
  • Identify and avoid personal dietary triggers.
  • Exercise moderately (30 minutes most days) to regulate vascular tone.
• Complementary approaches – Magnesium 400 mg daily, riboflavin 400 mg, or CoQ10 100 mg have modest evidence for migraine prophylaxis.

Prevention Tips

Because vertiginous migraine often follows predictable patterns, proactive measures can markedly cut attack frequency.

• Keep a migraine diary – Record foods, sleep, stress, weather, and hormone phases to pinpoint triggers.
• Adopt a migraine‑friendly diet – Emphasize whole grains, leafy greens, lean protein, and omega‑3 fatty acids; avoid processed foods, aged cheeses, and excessive salt.
• Regulate caffeine – Limit to ≤200 mg/day (≈2 cups coffee) and avoid abrupt cessation which can itself trigger migraines.
• Stress‑management techniques – Daily meditation, yoga, or progressive muscle relaxation.
• Consistent sleep hygiene – Same bedtime/wake‑time, dark cool bedroom, limit screens before bed.
• Stay active – Aerobic exercise improves vascular health and reduces migraine frequency.
• Hormone awareness – For women with menstrual‑related attacks, discuss hormonal contraceptives or perimenstrual triptan use with a provider.
• Protect your ears – Avoid prolonged exposure to loud noises; use earplugs when needed.
• Regular follow‑up – Review medication efficacy and side‑effects at least every 3–6 months.

Emergency Warning Signs

Bottom Line

Vertiginous (vestibular) migraine is a common but often under‑recognized cause of recurrent vertigo. Accurate diagnosis hinges on a thorough history, exclusion of other vestibular disorders, and adherence to established criteria. Treatment blends migraine‑focused medications with vestibular rehabilitation and lifestyle adjustments. Most patients achieve good control, but early recognition of red‑flag symptoms is essential to avoid missing serious neurological events.

For personalized advice, please consult a neurologist or an otolaryngology‑vestibular specialist. Reliable information can also be found at the Mayo Clinic, CDC, NIH, WHO, and the Cleveland Clinic.

```